NemaLife develops second-generation, AI-driven high-throughput organism-on-chip screening platform

Addressing market demand for rapid evaluation of novel ingredients, NemaLife enhances the capabilities of its in vivo screening platform LUBBOCK, Texas, Jan. 25, 2023 /PRNewswire/ — NemaLife Inc., a TechBio company, is delighted to announce that it has advanced the capabilities of its…

Click here to view original post